Myomo (MYO) Free Cash Flow (2016 - 2025)
Myomo's (MYO) quarterly Free Cash Flow came in at -$3.8 million in Q3 2025, down 107.94% on a YoY basis from $47.5 million in Q3 2024, and up 59.12% quarter-over-quarter from -$9.2 million in Q2 2025.
Analysis
Myomo (MYO) Free Cash Flow (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Free Cash Flow for 10 consecutive years, with -$3.8 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Free Cash Flow fell 107.94% year-over-year to -$3.8 million; the trailing twelve-month figure through Sep 2025 stood at -$13.8 million (down 45.1% YoY), and the FY2024 full-year result was -$4.7 million, up 26.41% from the prior year.
- Free Cash Flow rose to -$3.8 million in Q3 2025 per MYO's latest filing, from -$9.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.5 million in Q4 2024 and bottomed at -$9.2 million in Q2 2025.
- Historically, Free Cash Flow has averaged -$2.5 million across 5 years, with a median of -$2.4 million in 2022.
- The widest YoY moves for Free Cash Flow: up 204.95% in 2024, down 577.31% in 2024.
- Over 5 years, Free Cash Flow stood at -$1.9 million in 2021, then slumped by 33.21% to -$2.5 million in 2022, then gained by 3.25% to -$2.4 million in 2023, then jumped by 204.95% to $2.5 million in 2024, then plunged by 250.62% to -$3.8 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$3.8 million, -$9.2 million, and -$3.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 948.40 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.06 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.28 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 585.00 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 606.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 184.50 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3.77 Mn |
| Jun 30, 2025 | -9.23 Mn |
| Mar 31, 2025 | -3.35 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -300,496.00 |
| Mar 31, 2023 | -1.86 Mn |
| Dec 31, 2022 | -2.47 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Jun 30, 2022 | -2.70 Mn |
| Mar 31, 2022 | -2.37 Mn |
| Dec 31, 2021 | -1.85 Mn |
| Sep 30, 2021 | -2.26 Mn |
| Jun 30, 2021 | -3.60 Mn |
| Mar 31, 2021 | -2.16 Mn |
| Dec 31, 2020 | -1.15 Mn |